Adherium Brings In MicroDose Co-Founder As Senior VP
SmartInhaler developer Adherium has appointed the co-founder of MicroDose Therapeutx to head up its European base in Amsterdam, Netherlands.
You may also be interested in...
Developer of the SmartInhaler, Adherium Ltd, has established a European subsidiary which will be headed by John Tarplee, a veteran of the pharmaceutical industry with over 30 years’ experience. As Senior Vice-President Business development, Europe, Tarplee will lead market development and partnering activities in that region.
At the LSX World Congress in London, leaders from Medtronic, Johnson & Johnson and Olympus discussed the evolving medtech mergers and acquisitions landscape, the big opportunity in robotic surgery and the impacts on innovation of the forthcoming EU Medical Device Regulation.
Israeli start-up Serenno Medical is targeting 2020 for US FDA clearance and launch of its Sentinel device for early detection and prevention of acute kidney injury, a condition that affects 19 million patients worldwide every year.